Forbes June 30, 2022
In an environment as complex as health care, it should come as no surprise that artificial intelligence (AI) technology and the machine learning market are still relatively early-on in their maturation process. Expecting the market to be farther along would be like expecting a toddler who can do single-digit addition to also do calculus; we’re just not there yet. Yet.
The authors of a recent STAT+ article entitled “A market failure is preventing efficient diffusion of health care AI software,” make a case for why AI software adoption in health care remains limited, and what the industry can/should do to advance its implementation in a clinical decision support capacity.
To correct what they consider a “market failure,” the authors “offer...